Disease and Therapy Review: Melanoma

Timely Data Resources, Inc, November 2012, Pages: 14

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities.

Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.

The Melanoma Disease and Therapy Review provides an overview of skin cancer, with incidence, prevalence and mortality numbers, percentages and trends for major countries worldwide, and an overview of treatment by stage and type. Dosing and treatment cost information is provided for various treatment types. General information on the melanoma market, as well as sales of leading drugs and therapies are provided.

I. OVERVIEW
General description of the condition
Risk factors
Types of melanoma
Stages of disease

II. INCIDENCE, PREVALENCE AND MORTALITY
Incidence Table (Canada, U.S., Argentina, Brazil, Mexico, France, Germany, Greece, Italy, Poland, Russian Federation, Spain, Sweden, Turkey, UK, China, India, Japan, Korea, Philippines, Thailand, Egypt, South Africa, By Region, Worldwide) Prevalence Table (Canada, U.S., Argentina, Brazil, Mexico, France, Germany, Greece, Italy, Poland, Russian Federation, Spain, Sweden, Turkey, UK, China, India, Japan, Korea, Philippines, Thailand, Egypt, South Africa, By Region, More Developed, Less Developed, Worldwide) Mortality Table (Canada, U.S., Argentina, Brazil, Mexico, France, Germany, Greece, Italy, Poland, Russian Federation, Spain, Sweden, Turkey, UK, China, India, Japan, Korea, Philippines, Thailand, Egypt, South Africa, By Region, Worldwide)

III. TREATMENT
By stage
Chemotherapy
Radiation
Immunotherapy
Gene therapy

IV. DOSING
Dosing for approved melanoma treatments

V. TREATMENT COSTS
Estimates for overall costs of treating melanoma

VI. MARKET SIZE
Market overview
Sales information for key pharmaceuticals

VII. COMMENTS

VIII. REFERENCES/RESOURCES

Customers who bought this item also bought

• Active Pharmaceutical Ingredients (API) Market in Europe to 2017 - Pricing and Reimbursement Initiatives Supporting Generic Drug Growth, with CMOs Expected to Account for Majority of the Manufacturing Activity
• Global Biosimilars Market - Products, Applications and Regulations
• Global Pancreatic Cancer Epidemiology and Patient Flow Analysis - 2012
• Industrial Pharmaceutical Microbiology: Standards & Controls
• Global Type 1 Diabetes Epidemiology and Patient Flow Analysis - 2012
• Global Prostate Cancer Epidemiology and Patient Flow Analysis - 2012
• Global Overactive Bladder Epidemiology and Patient Flow Analysis - 2012
• Global Diabetic Retinopathy Epidemiology and Patient Flow Analysis - 2012
• Global Ulcerative Colitis Epidemiology and Patient Flow Analysis - 2012
• Global Insomnia Epidemiology and Patient Flow Analysis - 2012